ITALY – Mindray has introduced its premium ultrasound system, the Resona A20, at EUROSON 2024, the 35th Congress of the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB).
Designed to elevate medical diagnostics, the Resona A20 combines unmatched imaging precision with Acoustic Intelligence Technology (AIT), offering detailed insights into tissue structures, blood flow, and biological characteristics.
Equipped with advanced AFM transducer technology, the Resona A20 integrates Acoustic Boost, Free Band, and Matrix Thin Slice technologies to deliver exceptional imaging across various clinical applications.
This innovation enhances diagnostic confidence, as highlighted by Prof. Vito Cantisani, President-elect of EFSUMB, who stated, “The Resona A20 opens new functional prospects for daily clinical practice and educational research.”
The system also features AI-driven tools, including Smart Breast and Automated Liver STE, which streamline workflows and improve diagnostic accuracy.
Its Super-Resolution Contrast-Enhanced Ultrasound (SR CEUS) technology offers detailed views of microcirculation, revolutionizing cancer detection and treatment.
Prof. Ernst Michael Jung from University Hospital Regensburg commented, “With the A20, we can detect liver tumors as small as five millimeters, enabling transformative treatments like ablation therapies.”
Further enhancing its capabilities, the Resona A20 offers multi-parametric solutions that improve chronic liver disease assessments through tools like Visco-elastography and M Reference.
These tools provide comprehensive, non-invasive evaluations for conditions such as steatosis, fibrosis, and tumors in the liver and breast.
